Depressive Disorder Clinical Trial
— IPCASOfficial title:
Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents: Implementation and Effectiveness Study in School Health Care
The aim of this cluster randomized trial is to investigate whether the brief, 1+6 session
psychosocial intervention, Interpersonal Counseling (IPC) is more effective than standard
professional treatment (ST) in the treatment of mild or moderate depression among 12 to
17-year-old adolescents in services provided by school health care and counseling
professionals (school nurses, school psychologists and school social workers). The clients
are identified from the pool of adolescents routinely seen in school health care and
counseling services.
A total of 54 school nurses, social workers, and psychologists from all public secondary
schools in the standard education system of City of Espoo, Finland will be trained in IPC in
a three-day workshop in two waves. Each school (plus the one primary care level health care
unit for adolescents in Espoo) is represented by 1-3 trial IPC counselors. In the first wave
the schools are cluster randomized to provide either A) 1+6 sessions of IPC, or B) 1+6
sessions of standard treatment (ST), which consists of psychosocial work as guided by the
workers' own standard professional principles and methods. The workers randomized to deliver
IPC get the IPC training immediately. In the second wave those who delivered ST in the first
wave will be trained in IPC. The data for this trial will be collected from the first wave.
The data collection period is one school year plus follow-up of clients after 3 and 6
months.
The clients are adolescents who have either self-referred themselves, are referred by other
school personnel, or by parents to the services offered in the school due to emotional
symptoms in the school year 2016 -2017 in the participating schools. They are screened with
the BDI at the initial visit to identify depressive symptoms. A diagnostic interview will be
administered to those exceeding a clinical cutoff. Main inclusion criterion is DSM-5
depressive disorder of either mild or moderate severity. Those with current harmful alcohol
use, acute suicidal ideation or behavior, severe depression or anxiety disorder, psychotic
symptoms or very low global level of functioning are excluded and offered other treatment.
The clients will complete self-report questionnaires (BDI) as outcome measures. Their level
of depression symptoms will also be assessed with ADRS scale and their level of global
psychosocial functioning with the CGAS by the project IPC counselors / ST providers.
Moreover, the clients will complete the Young Person's Clinical Outcomes for Routine
Evaluation (YP-CORE) as a measure of global symptomatology after each session. A follow-up
interview at 3 months and 6 months after treatment termination will be arranged. The
K-SADS-PL will be used for diagnostic evaluation, the ADRS and the C-GAS to assess level of
depressive symptoms and global functioning, and the adolescent completes both the BDI and
YP-CORE as self-reports of symptomatology.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 2018 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 12 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of DSM-5 Depressive Disorder (severity mild or moderate) Exclusion Criteria: - current harmful alcohol use - acute suicidal ideation or behavior - severe depressive disorder - severe anxiety disorder - psychotic symptoms - very low global level of functioning |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Finland | Department of Adolescent Psychiatry, Helsinki University Central Hospital | Helsinki |
Lead Sponsor | Collaborator |
---|---|
Hospital District of Helsinki and Uusimaa | City of Espoo, Ministry of Social Affairs and Health; Finland, National Institute for Health and Welfare, Finland |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline in Adolescent Depression Rating Scale after six scheduled treatment sessions | 6 weeks | No | |
Primary | Change from Baseline in Children's Global Assessment of Functioning after six scheduled treatment sessions | 6 weeks | No | |
Primary | Change from Baseline in Beck Depression Inventory after six scheduled treatment sessions | 6 weeks | No | |
Primary | Change from Baseline in Young Person's Clinical Outcomes for Routine Evaluation after six scheduled treatment sessions | one, two, three, four, five, and six weeks | No | |
Secondary | Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 3 months after treatment termination | 3 months after treatment termination | No | |
Secondary | Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 6 months after treatment termination | 6 months after treatment termination | No | |
Secondary | Change from Baseline in Adolescent Depression Rating Scale 3 months after treatment termination | 3 months after treatment termination | No | |
Secondary | Change from Baseline in Adolescent Depression Rating Scale 6 months after treatment termination | 6 months after treatment termination | No | |
Secondary | Change from Baseline in Beck Depression Inventory 3 months after treatment termination | 3 months after treatment termination | No | |
Secondary | Change from Baseline in Beck Depression Inventory 6 months after treatment termination | 6 months after treatment termination | No | |
Secondary | Change from Baseline in Children's Global Assessment Scale 3 months after treatment termination | 3 months after treatment termination | No | |
Secondary | Change from Baseline in Children's Global Assessment Scale 6 months after treatment termination | 6 months after treatment termination | No | |
Secondary | Change from Baseline in Young Person's Clinical Outcomes for Routine Evaluation 3 months after treatment termination | 3 months after treatment termination | No | |
Secondary | Change from Baseline in Young Person's Clinical Outcomes for Routine Evaluation 6 months after treatment termination | 6 months after treatment termination | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01316926 -
Paxil CR Bioequivalence Study Brazil
|
Phase 1 | |
Recruiting |
NCT06187454 -
Transcranial Direct Current Stimulation for Depression
|
N/A | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05768126 -
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
|
Phase 4 | |
Completed |
NCT03219879 -
Telephone-administered Relapse Prevention for Depression
|
N/A | |
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT00069459 -
Seasonal Affective Depression (SAD) Study
|
Phase 1 | |
Recruiting |
NCT05503966 -
Combining Antidepressants and Attention Bias Modification in Depression
|
N/A | |
Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A | |
Completed |
NCT02542891 -
European Comparative Effectiveness Research on Internet-based Depression Treatment
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Withdrawn |
NCT02238730 -
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
|
N/A | |
Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01597661 -
Bupropion & Cardio Birth Defect (Slone)
|
N/A | |
Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A | |
Completed |
NCT01829100 -
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
|
N/A |